Anp Pharma Ltd

POWER SEARCH PRICING

SOLUTIONS

anp pharma ltd Company Information

Company Number

06111337

Next Accounts

Sep 2025

Directors

Amit Patel

Christopher Curran

View All

Shareholders

wescom signal & rescue uk limited

Group Structure

View All

Industry

Dispensing chemist in specialised stores

Registered Address

unit 9 honywood business park, honywood road, basildon, essex, SS14 3HW

Website

www.anppharma.co.uk

anp pharma ltd Estimated Valuation

£1.5m

Pomanda estimates the enterprise value of ANP PHARMA LTD at £1.5m based on a Turnover of £4.2m and 0.36x industry multiple (adjusted for size and gross margin).

Edit your figures and get a professional valuation report.

Anp Pharma Ltd is a live company located in basildon, SS14 3HW with a Companies House number of 06111337. It operates in the wholesale of pharmaceutical goods sector, SIC Code 46460. Founded in February 2007, it's largest shareholder is wescom signal & rescue uk limited with a 100% stake. Anp Pharma Ltd is a established, small sized company, Pomanda has estimated its turnover at £4.2m with healthy growth in recent years.

View Sample

Upgrade for unlimited company reports & a free credit check

Pomanda's financial health check has awarded Anp Pharma Ltd a 4 rating. We use a traffic light system to show it exceeds the industry average on 4 measures and has 6 areas for improvement. Company Health Check FAQs

Health Rating2.5out of 5

4 Strong

2 Regular

6 Weak

Size

annual sales of £4.1m, make it smaller than the average company (£18.4m)

Growth

3 year (CAGR) sales growth of 12%, show it is growing at a faster rate (5.7%)

EXPORT

Anp Pharma Ltd's latest turnover from December 2023 is £4.2 million and the company has net assets of £133.9 thousand. According to their latest financial statements, Anp Pharma Ltd has 11 employees and maintains cash reserves of £114.7 thousand as reported in the balance sheet.

Data source: Companies House, Pomanda Estimates

	Dec 2023	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013	Mar 2012	Mar 2011	Mar 2010
Turnover	4,167,903	4,128,140	2,855,921	2,639,566	2,907,575	1,473,363	1,494,158	1,090,784	1,459,549	1,220,122	1,256,297	2,388,496	821,874	956,739	1,034,268
Other Income Or Grants
Cost Of Sales	3,271,741	3,301,313	2,296,299	2,151,790	2,361,464	1,189,935	1,206,834	876,793	1,171,301	980,465	1,011,019	1,936,552	672,306	787,747	843,470
Gross Profit	896,162	826,828	559,623	487,776	546,112	283,428	287,324	213,991	288,248	239,657	245,278	451,945	149,568	168,991	190,798
Admin Expenses	1,563,973	883,641	420,258	523,878	-265,476	679,390	140,423	62,853	173,252	149,311	143,131	290,815	125,790	85,173	-121,503
Operating Profit	-667,811	-56,813	139,365	-36,102	811,588	-395,962	146,901	151,138	114,996	90,346	102,147	161,130	23,778	83,818	312,301
Interest Payable	34,446	5,458				1,126	3,406	5,714	8,581	5,944	2,067	3,528	6,787	10,386	6,044
Interest Receivable			6,226	821	589	2,256	2,196	1,163	1,766	1,797	1,235	610	678	1,108	767
Pre-Tax Profit	-702,257	-62,271	145,591	-35,281	812,177	-394,832	145,690	146,588	108,180	86,199	101,316	158,212	17,669	74,540	307,024
Tax	1,842		-27,662		-154,314		-27,681	-29,317	-21,636	-18,102	-23,303	-37,971	-4,594	-20,871	-85,967
Profit After Tax	-700,415	-62,271	117,929	-35,281	657,863	-394,832	118,009	117,270	86,544	68,097	78,013	120,241	13,075	53,669	221,057
Dividends Paid	175,150	150,000
Retained Profit	-875,565	-212,271	117,929	-35,281	657,863	-394,832	118,009	117,270	86,544	68,097	78,013	120,241	13,075	53,669	221,057
Employee Costs	565,789	695,763	408,172	382,941	359,611	284,170	314,114	178,679	148,682	148,289	144,560	251,222	83,780	111,273	113,642
Number Of Employees	11	10	9	9	9	7	8	5	5	5	5	9	3	4	4
EBITDA*	-624,635	4,259	218,658	-10,907	847,290	-271,556	212,665	182,471	179,621	165,412	150,472	200,279	61,369	123,405	354,640

* Earnings Before Interest, Tax, Depreciation and Amortisation

	Dec 2023	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013	Mar 2012	Mar 2011	Mar 2010
Tangible Assets	145,438	182,638	269,893	111,291	146,505	200,440	103,294	85,033	99,877	118,011	50,976	23,447	18,773	24,761	33,015
Intangible Assets						74,418	148,836	180,169	211,502	242,835	274,168	305,501	336,834	368,168	399,501
Investments & Other							1	1	1	1	1	1
Debtors (Due After 1 year)
Total Fixed Assets	145,438	182,638	269,893	111,291	146,505	274,858	252,131	265,203	311,380	360,847	325,145	328,949	355,607	392,929	432,516
Stock & work in progress	317,361	348,141	180,015	137,934	101,163	106,807	139,411	142,318	152,533	83,019	35,784	36,676	44,059	53,948	39,153
Trade Debtors	1,633,722	953,777	859,712	879,450	928,206	346,848	517,912	270,377	466,209	311,295	305,796	688,903	217,898	246,096	217,457
Group Debtors
Misc Debtors	97,269	188,870	291,413	154,232	263,868	159,159	91,015	170,666	183,491	101,976
Cash	114,699	396,023	915,244	745,046	896,115	281,936	319,699	558,540	372,124	334,106	384,586	109,448	134,708	136,512	306,759
misc current assets
total current assets	2,163,051	1,886,811	2,246,384	1,916,662	2,189,352	894,750	1,068,037	1,141,901	1,174,357	830,396	726,166	835,027	396,665	436,556	563,369
total assets	2,308,489	2,069,449	2,516,277	2,027,953	2,335,857	1,169,608	1,320,168	1,407,104	1,485,737	1,191,243	1,051,311	1,163,976	752,272	829,485	995,885
Bank overdraft							3,384	3,009	41,214	40,706
Bank loan
Trade Creditors	1,114,061	887,436	827,971	666,903	964,223	611,275	108,144	378,115	321,488	322,909	411,431	562,688	231,872	263,797	442,520
Group/Directors Accounts	894,278
other short term finances
hp & lease commitments		86,685	17,285
other current liabilities	128,388	53,117	329,854	246,410	219,882	77,090	287,639	187,685	395,255	141,116
total current liabilities	2,136,727	1,027,238	1,175,110	913,313	1,184,105	688,365	399,167	568,809	757,957	504,731	411,431	562,688	231,872	263,797	442,520
loans							29,981	68,430	70,195	111,918	30,268	33,324	75,242	133,593	185,971
hp & lease commitments
Accruals and Deferred Income
other liabilities			86,685								123,457	159,921	157,356	157,368	146,336
provisions	37,844	32,728	32,728	10,815	12,646		14,945	11,799	16,789	20,342
total long term liabilities	37,844	32,728	119,413	10,815	12,646		44,926	80,229	86,984	132,260	153,725	193,245	232,598	290,961	332,307
total liabilities	2,174,571	1,059,966	1,294,523	924,128	1,196,751	688,365	444,093	649,038	844,941	636,991	565,156	755,933	464,470	554,758	774,827
net assets	133,918	1,009,483	1,221,754	1,103,825	1,139,106	481,243	876,075	758,066	640,796	554,252	486,155	408,043	287,802	274,727	221,058
total shareholders funds	133,918	1,009,483	1,221,754	1,103,825	1,139,106	481,243	876,075	758,066	640,796	554,252	486,155	408,043	287,802	274,727	221,058

	Dec 2023	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013	Mar 2012	Mar 2011	Mar 2010
Operating Activities
Operating Profit	-667,811	-56,813	139,365	-36,102	811,588	-395,962	146,901	151,138	114,996	90,346	102,147	161,130	23,778	83,818	312,301
Depreciation	43,176	61,072	79,293	25,195	35,702	49,988	34,431		33,292	43,733	16,992	7,816	6,258	8,254	11,006
Amortisation						74,418	31,333	31,333	31,333	31,333	31,333	31,333	31,333	31,333	31,333
Tax	1,842		-27,662		-154,314		-27,681	-29,317	-21,636	-18,102	-23,303	-37,971	-4,594	-20,871	-85,967
Stock	137,346	168,126	42,081	36,771	-5,644	-32,604	-2,907	-10,215	69,514	47,235	-892	-7,383	-9,889	14,795	39,153
Debtors	579,866	-8,478	117,443	-158,392	686,067	-102,920	167,884	-208,657	236,429	107,475	-383,107	471,005	-28,198	28,639	217,457
Creditors	286,090	59,465	161,068	-297,320	352,948	503,131	-269,971	56,627	-1,421	-88,522	-151,257	330,816	-31,925	-178,723	442,520
Accruals and Deferred Income	-201,466	-276,737	83,444	26,528	142,792	-210,549	99,954	-207,570	254,139	141,116
Deferred Taxes & Provisions	5,116		21,913	-1,831	12,646	-14,945	3,146	-4,990	-3,553	20,342
Cash flow from operations	-1,250,265	-372,661	297,897	-161,909	520,939	141,605	-146,864	216,093	101,207	65,536	359,911	29,502	62,937	-119,623	454,583
Investing Activities
capital expenditure	81,279	26,183	-237,895	10,019	92,651	-147,134	-52,692	14,844	-15,158	-110,768	-44,521	-12,490	-269		-474,855
Change in Investments						-1						1
cash flow from investments	81,279	26,183	-237,895	10,019	92,651	-147,133	-52,692	14,844	-15,158	-110,768	-44,521	-12,491	-269		-474,855
Financing Activities
Bank loans
Group/Directors Accounts	894,278
Other Short Term Loans
Long term loans						-29,981	-38,449	-1,765	-41,723	81,650	-3,056	-41,918	-58,351	-52,378	185,971
Hire Purchase and Lease Commitments	-17,285	69,400	17,285
other long term liabilities	-86,685	-86,685	86,685							-123,457	-36,464	2,565	-12	11,032	146,336
share issue	-212,271										99				1
interest	-34,446	-5,458	6,226	821	589	1,130	-1,210	-4,551	-6,815	-4,147	-832	-2,918	-6,109	-9,278	-5,277
cash flow from financing	543,591	-22,743	110,196	821	589	-28,851	-39,659	-6,316	-48,538	-45,954	-40,253	-42,271	-64,472	-50,624	327,031
cash and cash equivalents
cash	-800,545	-519,221	170,198	-151,069	614,179	-37,763	-238,841	186,416	38,018	-50,480	275,138	-25,260	-1,804	-170,247	306,759
overdraft						-3,384	375	-38,205	508	40,706
change in cash	-800,545	-519,221	170,198	-151,069	614,179	-34,379	-239,216	224,621	37,510	-91,186	275,138	-25,260	-1,804	-170,247	306,759

Very Low Risk70 - 100

Low Risk50 - 70

Moderate Risk30 - 50

High Risk20 - 30

Very High Risk0 - 20

Get a comprehensive credit check for anp pharma ltd. Get real-time insights into anp pharma ltd's credit score, group structure and payment trends.

From as little as £6.99

This will not impact your credit rating!

View Credit Report Sample

Perform a competitor analysis for anp pharma ltd by selecting its closest rivals, whether from the WHOLESALE AND RETAIL TRADE; REPAIR OF MOTOR VEHICLES AND MOTORCYCLES sector, other small companies, companies in SS14 area or any other competitors across 12 key performance metrics.

ANP PHARMA LTD group structure

Anp Pharma Ltd has no subsidiary companies.

Ultimate parent company

THUNDERBOLT TOPCO LIMITED

FC037281

WESCOM SIGNAL AND RESCUE UK LIMITED

02937952

2 parents

ANP PHARMA LTD

06111337

ANP PHARMA LTD Shareholders

wescom signal & rescue uk limited

100%

Anp Pharma Ltd currently has 4 directors. The longest serving directors include Amit Patel (Feb 2007) and Mr Christopher Curran (Jun 2016).

officer	country	age	start	end	role
Amit Patel	England	44 years	Feb 2007	-	Director
Mr Christopher Curran	England	48 years	Jun 2016	-	Director
Ms Leanne Millar	United Kingdom	50 years	May 2023	-	Director
Mr Ross Wilkinson	United Kingdom	47 years	May 2023	-	Director

P&L

December 2023

turnover

4.2m

operating profit

-667.8k

gross margin

21.6%

-100%

turnover

Turnover, or revenue, is the amount of sales generated by a company within the financial year.

Balance Sheet

December 2023

net assets

133.9k

-0.89%

total assets

2.3m

-0.08%

cash

114.7k

-0.87%

net assets

Total assets minus all liabilities

Similar Companies

chelmack limited

k. waterhouse limited

4.5

lansdales pharmacy limited

4.5

aroschem limited

4.5

walter lloyd & son limited

company number

06111337

Type

Private limited with Share Capital

industry

47730 - Dispensing chemist in specialised stores

46460 - Wholesale of pharmaceutical goods

incorporation date

February 2007

ultimate parent company

THUNDERBOLT TOPCO LIMITED

previous names

N/A

address

unit 9 honywood business park, honywood road, basildon, essex, SS14 3HW

A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.

We found 6 charges/mortgages relating to anp pharma ltd. Currently there are 0 open charges and 6 have been satisfied in the past.

When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.

Click to start generating capital raising & share issue transactions for ANP PHARMA LTD. This can take several minutes, an email will notify you when this has completed.

anp pharma ltd Company Information

anp pharma ltd Estimated Valuation

anp pharma ltd Estimated Valuation

anp pharma ltd Estimated Valuation

Anp Pharma Ltd Overview

Anp Pharma Ltd Health Check

ANP PHARMA LTD financials

anp pharma ltd Credit Report and Business Information

Anp Pharma Ltd Competitor Analysis

anp pharma ltd Ownership

anp pharma ltd directors

anp pharma ltd company details

anp pharma ltd Charges & Mortgages

anp pharma ltd Capital Raised & Share Issues BETA

anp pharma ltd Companies House Filings - See Documents